Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients

被引:50
作者
Jeon, Min-Hyok [3 ]
Choi, Sang-Ho [1 ,2 ]
Kwak, Yee Gyung [1 ,2 ]
Chung, Jin-Won [1 ,2 ]
Lee, Sang-Oh [1 ,2 ]
Jeong, Jin-Yong [1 ,2 ,4 ]
Woo, Jun Hee [1 ,2 ]
Kim, Yang Soo [1 ,2 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Div Infect Dis, Seoul 138736, South Korea
[2] Univ Ulsan, Ctr Antimicrobial Resistance & Microbial Genet, Seoul 138736, South Korea
[3] Soonchunhyang Univ, Coll Med, Dept Infect Dis, Choongchungnam Do 336745, South Korea
[4] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul 138736, South Korea
关键词
Carbapenem; Resistance; Escherichia coli;
D O I
10.1016/j.diagmicrobio.2008.08.014
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Carbapenem resistance among Gram-negative bacilli has become an increasingly serious problem worldwide, and the emergence and spread of carbapenem-resistant Escherichia coli (CREC) is also becoming a serious problem. To date, however, risk factors for CREC acquisition have not been determined, so we decided to evaluate this in hospitalized patients through matched case-control study. Nosocomially acquired CREC was isolated from 46 patients between January 1997 and December 2007. For each patient, 3 matched-control subjects were selected. Previous use of carbapenem (adjusted odds ratio [AOR]. 6.50) and metronidazole (AOR, 4.25), the presence of biliary drainage catheter (AOR, 4.59), and prior hospital stay (AOR 1.02) were found as independent risk factors for CREC. Our results suggest that the nosocomial acquisition of CREC may be favored by the selection pressure of carbapenems and metronidazole and also related to prior hospital stay and the presence of biliary drainage catheter. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:402 / 406
页数:5
相关论文
共 27 条
[11]   Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients [J].
Harris, AD ;
Smith, D ;
Johnson, JA ;
Bradham, DD ;
Roghmann, MC .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (03) :340-345
[12]   Escherichia coli:: Development of carbapenem resistance during therapy [J].
Hong, T ;
Moland, ES ;
Abdalhamid, B ;
Hanson, ND ;
Wang, J ;
Sloan, C ;
Fabian, D ;
Faraiallah, A ;
Levine, J ;
Thomson, KS .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (10) :E84-E86
[13]   Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients [J].
Kwak, YG ;
Choi, SH ;
Choo, EJ ;
Chung, JW ;
Jeong, JY ;
Kim, NJ ;
Woo, JH ;
Ryu, J ;
Kim, YS .
MICROBIAL DRUG RESISTANCE, 2005, 11 (02) :165-169
[14]   Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii:: a case-control study [J].
Lee, SO ;
Kim, NJ ;
Choi, SH ;
Kim, TH ;
Chung, JW ;
Woo, JH ;
Ryu, J ;
Kim, YS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :224-228
[15]   Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: Comparison of clinical features and outcomes [J].
Lucas, GM ;
Lechtzin, N ;
Puryear, DW ;
Yau, LL ;
Flexner, CW ;
Moore, RD .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (05) :1127-1133
[16]   Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-β-lactamase VIM-1 [J].
Miriagou, V ;
Tzelepi, E ;
Gianneli, D ;
Tzouvelekis, LS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) :395-397
[17]   Novel IMP-1 metallo-β-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1 [J].
Moloughney, JG ;
Thomas, JD ;
Toney, JH .
FEMS MICROBIOLOGY LETTERS, 2005, 243 (01) :65-71
[18]  
National Committee for Clinical Laboratory Standards, 2004, M100S14 NCCLS
[19]   Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel [J].
Navon-Venezia, Shiri ;
Chmelnitsky, Inna ;
Leavitt, Azita ;
Schwaber, Mitchell J. ;
Schwartz, David ;
Carmeli, Yehuda .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (09) :3098-3101
[20]   In vivo acquisition of high-level resistance to imipenem in Escherichia coli [J].
Poirel, L ;
Héritier, C ;
Spicq, C ;
Nordmann, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (08) :3831-3833